Erythropoietin: a candidate compound for neuroprotection in schizophrenia
Open Access
- 28 October 2003
- journal article
- clinical trial
- Published by Springer Nature in Molecular Psychiatry
- Vol. 9 (1) , 42-54
- https://doi.org/10.1038/sj.mp.4001442
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Expression of Oct-6, a POU III Domain Transcription Factor, in SchizophreniaAmerican Journal of Psychiatry, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Traumatic Brain Injury and Schizophrenia in Members of Schizophrenia and Bipolar Disorder PedigreesAmerican Journal of Psychiatry, 2001
- Glutathione S-transferase M1 Gene Deletion May Be Associated with Susceptibility to Certain Forms of SchizophreniaBiochemical and Biophysical Research Communications, 2001
- Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental modelAustralian & New Zealand Journal of Psychiatry, 2000
- Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivoEuropean Journal of Neuroscience, 2000
- The Nagging Question of the Function ofN-AcetylaspartylglutamateNeurobiology of Disease, 1997
- Paranoid Disorders following War Brain DamagePsychopathology, 1991
- A technique for repeated sampling of CSF from the anesthetized ratPhysiology & Behavior, 1986
- The Distribution of Active Bone Marrow in the AdultPhysics in Medicine & Biology, 1961